Analysis Group Honored by Global Competition Review for Work on AbbVie/Allergan Merger

June 2, 2021

Analysis Group was recognized by Global Competition Review (GCR) for its work on the $63 billion acquisition of Allergan by AbbVie, which was named GCR’s 2020 Merger Control Matter of the Year – Americas. An Analysis Group team led by Managing Principal Rebecca Kirk Fair and Vice President Emily Cotton was retained by Weil, Gotshal & Manges on behalf of Allergan, and provided competitive analyses in support of the merger, which was approved by both the EU and the US Federal Trade Commission.

Read more about the GCR Awards 2021

Read more about Analysis Group’s work on the merger